As the prevalence of obesity, type 2 diabetes, and the opioid crisis in the United States continues to rise, so does chronic liver disease. From hepatitis C and hepatitis B to non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH), liver disease affects a significant portion of the U.S. population. Hepatitis C virus (HCV) is a leading cause of cirrhosis, liver cancer, and mortality worldwide. Injection drug use, arising in conjunction with the opioid crisis, has contributed significantly to the increase in HCV infections. Chronic hepatitis B virus (HBV) remains a global epidemic, resulting in significantly increased morbidity and mortality. Furthermore, the rising number of obese and diabetic patients has resulted in the increased prevalence of NAFLD, which may progress to NASH in a large number of patients. To help clinicians and patients navigate the changing landscape of liver disease, we designed the Liver Disease Hub to provide resources and guidelines for screening, testing, and treatment of liver disease.

Our activities offer many credit types, including CME, AAFP Prescribed Credit, CNE, CPE, ABIM MOC, and ABP MOC. Each activity has been designed to meet the requirements for CME for MIPS. See each activity’s information page for the exact credit type and amount of credit offered.

Creating Action Steps for Linking Underserved Populations with Hepatitis C Care

Participate Now

Hear expert insights on creating action steps to improve access to Hepatitis C care for patients within underserved populations in this upcoming CME Outfitters Live and OnDemand webcast. Expert faculty will discuss the many barriers to treating HCV in the injection drug use population, including stigma and established negative perceptions about people who inject drugs (PWID), with special attention paid to applying CDC universal screening guidelines to improve diagnosis and linkage to treatment, expanding treatment for HCV in primary care settings, and addressing disparities in HCV treatment initiation in underserved communities.

Test Your Knowledge: An Interactive Session on Emerging Data and Expert Insights on Hepatitis B

Participate Now

Test your knowledge during this interactive CME Outfitters Live and OnDemand webcast featuring augmented reality animations that will reinforce the fibrotic consequence of untreated HBV. Data presentation and translation will showcase the importance of implementing routine screening protocols, optimizing efficacy and safety profiles of current agents when initiating or switching treatment, and routinely monitoring patients with HBV for disease progression HCC, and HBV reactivation.

Research You Can Use: Impact of the 2020 COVID-19 Pandemic on Ambulatory Hepatitis C Testing

Participate Now

COVID-19 has presented many challenges for health care providers and hospital systems. In this edition of Research You Can Use, Dr. Gold reviews an article by Heather Sperring, MS, and colleagues from Boston Medical Center entitled, “Impact of the 2020 COVID-19 Pandemic on Ambulatory Hepatitis C Testing,” published in the Journal of Primary Care & Community Health, that outlines the negative impact of the pandemic on hepatitis C testing and the resulting consequences of the decrease in HCV identification.

Test Your Knowledge: An Interactive Session on Emerging Data and Expert Insights in Hepatitis B

Participate Now

Test your knowledge during this interactive CME Outfitters OnDemand webcast, featuring augmented reality animations that will reinforce the fibrotic consequence of untreated HBV. Data presentation and translation will showcase the importance of implementing routine screening protocols, optimizing efficacy and safety profiles of current agents when initiating or switching treatment, and routinely monitoring patients with HBV for disease progression HCC, and HBV reactivation.

Saturday Morning Coffee with Experts in NASH: What Is The Update?

Participate Now

In this CME Outfitters webcast, a renowned panel of experts will highlight the underlying mechanisms of NASH via innovative augmented reality (AR) animations and present real-world case scenarios to share clinical insights on how to choose appropriate non-invasive diagnostic modalities, as well as translate latest data on emerging targeted therapies and their implications for clinical practice.

Streamlining the Journey to a Cure: Optimizing the Hepatitis C Virus Care Cascade

Participate Now

Recent studies have shown persistent gaps in the HCV care continuum, with underdiagnosis and undertreatment being the major barriers toward achieving the goal of eliminating HCV. With primary care clinicians and community health workers representing an important front-line resource for early screening and treatment for HCV infection, it is imperative to educate primary care providers (PCPs) and community health workers to expand the HCV workforce and linkage-to-care opportunities.  This CME Outfitters on-demand webcast features expert faculty hosting an interactive discussion on implementing HCV screening, developing new methods of coordinated care, and addressing barriers to treatment access.

 

 

At-Risk Patients Hidden in Plain Sight: Real-World Strategies for Screening and Treating Hepatitis B Virus

Participate Now

In this CME Outfitters virtual symposium, expert faculty utilized augmented reality to add visualization to their discussion of how to implement routine screening protocols for HBV in primary care settings, how to optimize the efficacy and safety profiles of current

A Deeper Dive into NASH Diagnosis and Treatment: An Augmented Reality Experience

Participate Now

With the majority of high-risk patients first seen in the primary care setting, it is imperative that internists and primary care physicians (PCPs) identify patients at risk for NASH. Although liver biopsy was previously the best test for identifying the critical endpoints of NASH, several noninvasive, yet effective, tests have been developed recently that have the potential to be implemented in primary care settings. In this CME Outfitters webcast, expert faculty utilized Augmented Reality (AR) to visually dive into NASH, with particular focus on risk stratification, diagnosis, and emerging targeted therapies.

The HBV Refresher: Screen, Diagnose, Treat

Participate Now

The first episode of this CMEOcast series on community-based efforts to improve screening and treatment of HBV will guide primary care clinicians through optimal strategies to screen for HBV in at-risk patients and utilize serological test results to drive guideline-directed care.

HBV Treatment Decision-Making

Participate Now

In this second episode of the four-part CMEOCast Podcast to Practice series “Meeting Patients Where They Live: Community-Based Efforts to Improve Screening and Treatment of HBV,” faculty experts will discuss the efficacy and safety profiles of current agents for HBV, guiding clinicians through best practices when initiating or switching treatment. In addition, while there is currently no cure for HBV, considering the promise for the future, faculty experts will define “functional cure” for HBV and its application to agents in development.

Public Health Opportunities in the ED: Step 1: Screen for HBV, Step 2: Link to Care

Participate Now

The third episode of this CMEOCast podcast series focuses on best practices for screening for HBV in the ED, incorporating the use of interprofessional teams, and fostering patient education for optimal treatment outcomes.

Long-Term Management of HBV: Meeting the Culturally Diverse Needs of Your Patient Community

Participate Now

The final episode of this CME Outfitters podcast series aims to provide learners with strategies to provide culturally appropriate counseling and support services to high-risk populations in order to optimize retention and long-term HBV care.

NASH

NASH Pathophysiology

In this video, Dr. Mazen Noureddin uses an augmented reality animation of the human liver to describe how nonalcoholic steatohepatitis (NASH) emerges.

Molecular Targets for Emerging Therapies for NASH

In this video, Dr. Mazen Noureddin uses an augmented reality animation of the human liver to review molecules that play key roles in NASH pathophysiology and have thus been identified as targets for the development of pharmacotherapies for NASH.

An Animated Tour of the Mechanisms of HBV

In this video, Dr. Kris Kowdley uses an augmented reality animation to discuss the mechanisms involved with hepatitis B viral infection of the liver. Click the closed caption button to select subtitles in Vietnamese, Chinese (traditional), Chinese (simplified), Hmong, or Korean.

An Examination of the Stages of Fibrosis (for Clinicians)

In this video, Dr. Kris Kowdley uses an augmented reality animation to discuss the stepwise process of fibrosis progression from one stage to another. Click the closed caption button to select subtitles in Vietnamese, Chinese (traditional), Chinese (simplified), Hmong, or Korean.

The Mechanisms of HBV-Induced Hepatocellular Carcinoma

In this video, Dr. Kris Kowdley uses an augmented reality animation to discuss the primary mechanisms by which hepatitis B virus is thought to promote liver cancer. Click the closed caption button to select subtitles in Vietnamese, Chinese (traditional), Chinese (simplified), Hmong, or Korean.

An Examination of the Stages of Fibrosis (for Patients)

In this video, Dr. Kris Kowdley uses an augmented reality animation to discuss the various stages of fibrosis and the impact on the liver during each stage. Click the closed caption button to select subtitles in Vietnamese, Chinese (traditional), Chinese (simplified), Hmong, or Korean.

A Brief Overview of the Types of Hepatitis (for Patients)

In this animation, Dr. Kris Kowdley discusses the three most common viruses that cause hepatitis (hepatitis A virus, hepatitis B virus, and hepatitis C virus) and how each is transmitted. Click the closed caption button to select subtitles in Vietnamese, Chinese (traditional), Chinese (simplified), Hmong, or Korean.